Abstract
This follow-up study investigates the metabolic and psychosocial effects of sensor-augmented pump (SAP) therapy in adults with type 1 diabetes 36 months after therapy start.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes Technology & Therapeutics |
Vol/bind | 14 |
Udgave nummer | 12 |
Sider (fra-til) | 1174-7 |
Antal sider | 4 |
ISSN | 1520-9156 |
DOI | |
Status | Udgivet - 2012 |